Emerging Diseases News

SARS-CoV-2 rebound risk is more likely related to the individual person, rather than reinfection or resistance to treatment such as Paxlovid, according to two studies.

Healio reporters filed more than 100 stories from infectious diseases meetings in 2023, most of them on the road in cities like Boston, Philadelphia, Orlando, Houston and Seattle.

The FDA in 2023 approved treatments for several hospital-associated infections and fully approved a long-used COVID-19 medication, among other non-vaccine-related regulatory decisions.

Rates of STDs continue to rise in the United States, with CDC data showing increases year after year.

Major vaccine developments in 2023 included the approvals of the first two vaccines against respiratory syncytial virus, the first chikungunya vaccine, a new vaccine against malaria, and a move to new monovalent COVID-19 vaccines.

On Dec. 14, the CDC issued an urgent warning calling for health care providers to increase vaccination coverage for COVID-19, influenza and respiratory syncytial virus.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

As the COVID-19 pandemic enters its 5th year, its effect on children continues to be widely studied. We compiled a list of stories about pediatric COVID-19 that we reported over the course of the past year.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

SAN DIEGO — COVID-19 vaccine boosters led to a significantly increased antibody response in patients using abatacept or TNF inhibitors regardless of whether they held medication, according to data presented at ACR Convergence 2023.